- Home
- GDTC vs FLUX Comparison
GDTC vs FLUX Comparison
Compare GDTC & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- FLUX
- Stock Information
- Founded
- GDTC 2018
- FLUX N/A
- Country
- GDTC Singapore
- FLUX United States
- Employees
- GDTC N/A
- FLUX N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- FLUX Industrial Machinery/Components
- Sector
- GDTC Health Care
- FLUX Miscellaneous
- Exchange
- GDTC Nasdaq
- FLUX Nasdaq
- Market Cap
- GDTC 21.5M
- FLUX 25.4M
- IPO Year
- GDTC 2023
- FLUX N/A
- Fundamental
- Price
- GDTC $1.89
- FLUX $1.71
- Analyst Decision
- GDTC Buy
- FLUX Strong Buy
- Analyst Count
- GDTC 1
- FLUX 2
- Target Price
- GDTC $5.00
- FLUX $6.00
- AVG Volume (30 Days)
- GDTC 18.1K
- FLUX 134.5K
- Earning Date
- GDTC 01-01-0001
- FLUX 08-15-2025
- Dividend Yield
- GDTC N/A
- FLUX N/A
- EPS Growth
- GDTC N/A
- FLUX N/A
- EPS
- GDTC N/A
- FLUX N/A
- Revenue
- GDTC $368,838.00
- FLUX $63,074,000.00
- Revenue This Year
- GDTC $5.37
- FLUX $11.10
- Revenue Next Year
- GDTC N/A
- FLUX $12.66
- P/E Ratio
- GDTC N/A
- FLUX N/A
- Revenue Growth
- GDTC N/A
- FLUX N/A
- 52 Week Low
- GDTC $1.20
- FLUX $1.15
- 52 Week High
- GDTC $4.05
- FLUX $3.78
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- FLUX 44.00
- Support Level
- GDTC $1.85
- FLUX $1.70
- Resistance Level
- GDTC $1.95
- FLUX $2.15
- Average True Range (ATR)
- GDTC 0.10
- FLUX 0.19
- MACD
- GDTC -0.02
- FLUX -0.04
- Stochastic Oscillator
- GDTC 28.00
- FLUX 2.06
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.